US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Neurocrine Biosciences

152.57

-0.3600-0.24%

Post-market: 152.570.00000.00%19:43 EDT

Volume:1.23M

Turnover:188.30M

Market Cap:15.56B

PE:22.36

High:155.27

Open:153.13

Low:152.51

Close:152.93

52wk High:186.12

52wk Low:122.14

Shares:102.00M

Float Shares:100.00M

Volume Ratio:1.11

T/O Rate:1.23%

Dividend:- -

Dividend Rate:- -

EPS(TTM):6.82

EPS(LYR):4.67

ROE:22.09%

ROA:11.70%

PB:4.21

PE(LYR):32.67

Loading ...

Overview Company News Filings

Neurocrine Begins Phase 2 Trial of Crinecerfont in Children Under 4 Years With Classic CAH Genetic Condition

MT Newswires Live

Neurocrine initiates Phase 2 study of crinecerfont

Neurocrine Biosciences Announces Press Release Available on Pediatric Crinecerfont Phase 2 CAH Study Initiation

Neurocrine Biosciences Initiates Phase 2 Study of Crinecerfont in Pediatric Patients Under 4 Years Old with Classic Congenital Adrenal Hyperplasia

THOMSON REUTERS

Neurocrine Biosciences Chief Legal Officer Darin Lippoldt Sells USD 1.91 Million in Common Shares

Neurocrine Biosciences' Ingrezza Momentum Seen Supporting 2026 Guidance Upgrade, UBS Says

MT Newswires Live

Neurocrine (NBIX) Receives a Buy from Jefferies

Neurocrine price target raised to $208 from $182 at UBS

Neurocrine Biosciences, Inc : Jefferies Raises Target Price to $200 from $181

THOMSON REUTERS

What Neurocrine Biosciences (NBIX)'s New CRENESSITY CAH Data Means For Shareholders

Simply Wall St.

Deutsche Bank Raises Neurocrine Biosciences Price Target to $170 From $155, Maintains Hold Rating

MT Newswires Live

Neurocrine Biosciences, Inc. : Deutsche Bank Raises Target Price to $170 From $155

THOMSON REUTERS

U.S. RESEARCH ROUNDUP-Baldwin Insurance Group, Diamondback Energy, Visteon

Neurocrine’s Valbenazine Huntington Study Completion Signals Next Phase for NBIX Investors

Neurocrine presents first retrospective case series of Crenessity

Neurocrine presents two-year Crenessity data

Neurocrine reports 2-year Phase 3 CAHtalyst Adult data showing cardiometabolic gains with CRENESSITY in classic CAH

Vir Biotechnology names Timothy Coughlin to board, taps him as audit committee chair

Neurocrine Biosciences director Stephen A. Sherwin disposes of USD 4.12 million in common shares

Neurocrine director Leslie V Norwalk disposes of USD 210,071.63 in common shares

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/NBIX/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"NBIX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NBIX\",,,,,undefined,":{"symbol":"NBIX","market":"US","secType":"STK","nameCN":"Neurocrine Biosciences","latestPrice":152.57,"timestamp":1787342400000,"preClose":152.93,"halted":0,"volume":1227625,"hourTrading":{"tag":"盘后","latestPrice":152.57,"preClose":152.57,"latestTime":"19:43 EDT","volume":42081,"amount":6434214.421,"timestamp":1787355831826,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.0023540181782515765,"floatShares":99995570,"shares":102000000,"eps":6.823004,"marketStatus":"Not Yet Opened","change":-0.36,"latestTime":"08-21 16:00:00 EDT","open":153.13,"high":155.265,"low":152.51,"amount":188300831.98499998,"amplitude":0.018015,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":6.823004,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":832824000000,"exchange":"NASDAQ","adjPreClose":152.93,"preHourTrading":{"tag":"盘前","latestPrice":152.93,"preClose":152.93,"latestTime":"09:25 EDT","volume":27,"amount":4168.59129,"timestamp":1787318735001,"change":0,"changeRate":0,"amplitude":0.051527},"postHourTrading":{"tag":"盘后","latestPrice":152.57,"preClose":152.57,"latestTime":"19:43 EDT","volume":42081,"amount":6434214.421,"timestamp":1787355831826,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.1069192222404156,"impliedVol":0.2965,"impliedVolPercentile":0.2191},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NBIX\",,,,,undefined,":{"symbol":"NBIX","floatShares":99995570,"roa":"11.70%","roe":"22.09%","lyrEps":4.67,"volumeRatio":1.1069192222404156,"shares":102000000,"dividePrice":0,"high":155.265,"amplitude":0.018015,"preClose":152.93,"low":152.51,"week52Low":122.1375,"pbRate":"4.21","psRate":"4.61","week52High":186.12,"institutionHeld":0.9909,"latestPrice":152.57,"eps":6.823004,"divideRate":0,"volume":1227625,"delay":0,"ttmEps":6.823004,"open":153.13,"prevYearClose":141.83,"prevWeekClose":152.72,"prevMonthClose":166.8,"prevQuarterClose":168.535,"fiveDayClose":152.72,"twentyDayClose":175.77,"sixtyDayClose":155.83},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NBIX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-07-30","symbol":"NBIX","fiscalQuarterEnding":"2026/06","expectedEps":1.88,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785384000000,"reportTimeType":"post","actualEps":2.36},{"market":"US","date":"2026-05-05","symbol":"NBIX","fiscalQuarterEnding":"2026/03","expectedEps":1.28,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1777953600000,"reportTimeType":"post","actualEps":1.41},{"market":"US","date":"2026-02-11","symbol":"NBIX","fiscalQuarterEnding":"2025/12","expectedEps":1.78,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1770786000000,"reportTimeType":"post","actualEps":1.43},{"market":"US","date":"2025-10-28","symbol":"NBIX","fiscalQuarterEnding":"2025/09","expectedEps":1.58,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1761624000000,"reportTimeType":"post","actualEps":2.04},{"market":"US","date":"2025-07-30","symbol":"NBIX","fiscalQuarterEnding":"2025/06","expectedEps":0.98,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1753848000000,"reportTimeType":"post","actualEps":1.06}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NBIX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NBIX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.4667,"hold":0.1333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4667,"analysts":30,"updateTime":1780459200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NBIX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NBIX","date":"2026-08-21","current":22.361118,"percent":0.059446,"low":15.452095,"twenty":27.727905,"median":40.453654,"eighty":110.387029,"high":905.986584,"avg":99.923304,"sd":176.088721,"marketCap":15545209250},"quantilePoints":[{"date":"2021-08-27","current":24.711359,"twenty":-58.891511,"median":21.503477,"eighty":264.839255,"marketCap":9012232778},{"date":"2021-09-03","current":24.880046,"twenty":-57.788755,"median":21.578659,"eighty":264.839255,"marketCap":9073752956},{"date":"2021-09-10","current":25.105828,"twenty":-57.393419,"median":21.731847,"eighty":264.839255,"marketCap":9156095347},{"date":"2021-09-17","current":25.043543,"twenty":-57.122936,"median":21.874823,"eighty":264.839255,"marketCap":9133380205},{"date":"2021-09-24","current":24.65167,"twenty":-56.515676,"median":21.983228,"eighty":264.839255,"marketCap":8990464100},{"date":"2021-10-01","current":26.330755,"twenty":-56.073302,"median":22.061434,"eighty":264.839255,"marketCap":9602826483},{"date":"2021-10-08","current":27.010694,"twenty":-54.272284,"median":22.130844,"eighty":264.839255,"marketCap":9850800122},{"date":"2021-10-15","current":27.130073,"twenty":-53.483205,"median":22.199493,"eighty":264.839255,"marketCap":9894337478},{"date":"2021-10-22","current":26.870554,"twenty":-53.14751,"median":22.365311,"eighty":264.839255,"marketCap":9799691051},{"date":"2021-10-29","current":27.355854,"twenty":-53.059611,"median":22.416552,"eighty":264.839255,"marketCap":9976679870},{"date":"2021-11-05","current":19.879776,"twenty":-52.91578,"median":22.430689,"eighty":264.839255,"marketCap":8842524454},{"date":"2021-11-12","current":18.76859,"twenty":-52.59512,"median":22.430689,"eighty":264.839255,"marketCap":8348268984},{"date":"2021-11-19","current":18.346297,"twenty":-52.419753,"median":22.430689,"eighty":264.839255,"marketCap":8160432931},{"date":"2021-11-26","current":18.551045,"twenty":-52.090504,"median":22.430689,"eighty":264.839255,"marketCap":8251504957},{"date":"2021-12-03","current":16.994105,"twenty":-51.971325,"median":22.430689,"eighty":264.839255,"marketCap":7558978098},{"date":"2021-12-10","current":16.987707,"twenty":-51.971325,"median":22.430689,"eighty":264.839255,"marketCap":7556132097},{"date":"2021-12-17","current":18.476398,"twenty":-51.971325,"median":22.430689,"eighty":264.839255,"marketCap":8218301614},{"date":"2021-12-23","current":18.147947,"twenty":-51.971325,"median":22.430689,"eighty":264.839255,"marketCap":8072206907},{"date":"2021-12-31","current":18.16501,"twenty":-51.971325,"median":22.430689,"eighty":264.839255,"marketCap":8079796242},{"date":"2022-01-07","current":16.064207,"twenty":-51.955042,"median":22.42362,"eighty":264.609771,"marketCap":7145359316},{"date":"2022-01-14","current":16.712577,"twenty":-51.955042,"median":22.42362,"eighty":264.609771,"marketCap":7433754063},{"date":"2022-01-21","current":16.017286,"twenty":-51.955042,"median":22.42362,"eighty":264.609771,"marketCap":7124488644},{"date":"2022-01-28","current":16.364931,"twenty":-51.955042,"median":22.42362,"eighty":264.609771,"marketCap":7279121353},{"date":"2022-02-04","current":17.305493,"twenty":-51.955042,"median":22.42362,"eighty":264.609771,"marketCap":7697483470},{"date":"2022-02-11","current":90.557458,"twenty":-51.955042,"median":22.431842,"eighty":264.609771,"marketCap":8113948252},{"date":"2022-02-18","current":90.693144,"twenty":-51.955042,"median":22.522526,"eighty":264.609771,"marketCap":8126105713},{"date":"2022-02-25","current":94.45608,"twenty":-51.955042,"median":22.586516,"eighty":264.609771,"marketCap":8463264811},{"date":"2022-03-04","current":93.743886,"twenty":-51.955042,"median":22.661461,"eighty":264.609771,"marketCap":8399452213},{"date":"2022-03-11","current":94.91316,"twenty":-51.955042,"median":22.80063,"eighty":264.609771,"marketCap":8504219165},{"date":"2022-03-18","current":98.99499,"twenty":-51.908672,"median":22.903884,"eighty":264.609771,"marketCap":8869951067},{"date":"2022-03-25","current":99.622146,"twenty":-51.908672,"median":23.045631,"eighty":264.609771,"marketCap":8926144250},{"date":"2022-04-01","current":101.588652,"twenty":-51.908672,"median":23.1378,"eighty":264.609771,"marketCap":9102343214},{"date":"2022-04-08","current":106.372046,"twenty":-51.908672,"median":23.19199,"eighty":264.609771,"marketCap":9530935287},{"date":"2022-04-14","current":105.521665,"twenty":-51.879725,"median":23.286066,"eighty":264.609771,"marketCap":9454741141},{"date":"2022-04-22","current":99.794282,"twenty":-51.235376,"median":23.504791,"eighty":264.609771,"marketCap":8941567652},{"date":"2022-04-29","current":95.96752,"twenty":-50.869461,"median":23.733072,"eighty":264.609771,"marketCap":8598689764},{"date":"2022-05-06","current":106.411117,"twenty":-50.538701,"median":24.05378,"eighty":264.609771,"marketCap":7597753757},{"date":"2022-05-13","current":112.603765,"twenty":-50.513367,"median":24.270178,"eighty":264.609771,"marketCap":8039908807},{"date":"2022-05-20","current":115.361299,"twenty":-50.513367,"median":24.572517,"eighty":264.609771,"marketCap":8236796731},{"date":"2022-05-27","current":124.624471,"twenty":-50.513367,"median":24.659455,"eighty":264.609771,"marketCap":8898187232},{"date":"2022-06-03","current":127.890676,"twenty":-50.513367,"median":24.724335,"eighty":264.609771,"marketCap":9131394287},{"date":"2022-06-10","current":126.244188,"twenty":-50.513367,"median":24.885236,"eighty":264.609771,"marketCap":9013834993},{"date":"2022-06-17","current":124.865421,"twenty":-50.513367,"median":25.0449,"eighty":264.609771,"marketCap":8915391031},{"date":"2022-06-24","current":131.50492,"twenty":-50.518997,"median":25.258455,"eighty":264.839255,"marketCap":9389451274},{"date":"2022-07-01","current":132.856915,"twenty":-50.518997,"median":25.998572,"eighty":264.839255,"marketCap":9485983703},{"date":"2022-07-08","current":127.930835,"twenty":-50.518997,"median":26.276232,"eighty":264.839255,"marketCap":9134261587},{"date":"2022-07-15","current":127.395391,"twenty":-50.518997,"median":26.439753,"eighty":264.839255,"marketCap":9096030922},{"date":"2022-07-22","current":127.556024,"twenty":-50.518997,"median":26.634392,"eighty":264.839255,"marketCap":9107500121},{"date":"2022-07-29","current":126.003238,"twenty":-50.518997,"median":26.826436,"eighty":264.839255,"marketCap":8996631194},{"date":"2022-08-05","current":815.065239,"twenty":-50.518997,"median":26.995123,"eighty":267.473329,"marketCap":9943795914},{"date":"2022-08-12","current":828.064055,"twenty":-50.518997,"median":27.355854,"eighty":332.018448,"marketCap":10102381477},{"date":"2022-08-19","current":838.803881,"twenty":-50.518997,"median":43.704114,"eighty":339.430085,"marketCap":10233407347},{"date":"2022-08-26","current":822.106196,"twenty":-50.518997,"median":44.350706,"eighty":343.175456,"marketCap":10029695593},{"date":"2022-09-02","current":807.525119,"twenty":-50.518997,"median":44.8698,"eighty":348.23866,"marketCap":9851806456},{"date":"2022-09-09","current":834.962629,"twenty":-50.518997,"median":45.079259,"eighty":349.917301,"marketCap":10186544079},{"date":"2022-09-16","current":831.670128,"twenty":-50.518997,"median":45.502731,"eighty":362.813526,"marketCap":10146375564},{"date":"2022-09-23","current":811.366371,"twenty":-50.518997,"median":45.962631,"eighty":364.154541,"marketCap":9898669723},{"date":"2022-09-30","current":832.610843,"twenty":-50.518997,"median":46.285926,"eighty":365.308101,"marketCap":10157852283},{"date":"2022-10-07","current":848.602992,"twenty":-50.518997,"median":47.210279,"eighty":371.273896,"marketCap":10352956498},{"date":"2022-10-14","current":848.446206,"twenty":-50.518997,"median":49.327638,"eighty":378.797857,"marketCap":10351043711},{"date":"2022-10-21","current":869.690678,"twenty":-50.518997,"median":50.903135,"eighty":389.463975,"marketCap":10610226271},{"date":"2022-10-28","current":905.986584,"twenty":-50.518997,"median":51.513299,"eighty":431.928138,"marketCap":11053036327},{"date":"2022-11-04","current":201.221497,"twenty":-50.458475,"median":52.087035,"eighty":434.881702,"marketCap":11711091146},{"date":"2022-11-11","current":200.593816,"twenty":-50.126307,"median":52.792822,"eighty":434.881702,"marketCap":11674560078},{"date":"2022-11-18","current":198.47952,"twenty":-49.947556,"median":54.395533,"eighty":434.881702,"marketCap":11551508062},{"date":"2022-11-25","current":201.766589,"twenty":-49.629464,"median":57.560591,"eighty":434.881702,"marketCap":11742815494},{"date":"2022-12-02","current":209.463947,"twenty":-49.385812,"median":59.991394,"eighty":434.881702,"marketCap":12190801742},{"date":"2022-12-09","current":193.656283,"twenty":-48.929381,"median":62.264354,"eighty":434.881702,"marketCap":11270795649},{"date":"2022-12-16","current":193.573693,"twenty":-48.286719,"median":62.627396,"eighty":434.881702,"marketCap":11265988929},{"date":"2022-12-23","current":198.727289,"twenty":-40.846451,"median":63.253512,"eighty":434.881702,"marketCap":11565928220},{"date":"2022-12-30","current":197.290229,"twenty":-39.648276,"median":63.753352,"eighty":434.881702,"marketCap":11482291302},{"date":"2023-01-06","current":203.20365,"twenty":-39.648276,"median":64.910878,"eighty":434.881702,"marketCap":11826452411},{"date":"2023-01-13","current":180.028985,"twenty":-39.648276,"median":65.66327,"eighty":434.881702,"marketCap":10477686948},{"date":"2023-01-20","current":183.943736,"twenty":-39.648276,"median":66.031573,"eighty":434.881702,"marketCap":10705525447},{"date":"2023-01-27","current":178.806658,"twenty":-37.833689,"median":67.168053,"eighty":434.881702,"marketCap":10406547501},{"date":"2023-02-03","current":181.746851,"twenty":-35.951624,"median":67.783646,"eighty":434.881702,"marketCap":10577666711},{"date":"2023-02-10","current":64.510722,"twenty":15.966099,"median":67.783646,"eighty":434.881702,"marketCap":9966906536},{"date":"2023-02-17","current":64.729529,"twenty":16.188336,"median":67.783646,"eighty":434.881702,"marketCap":10000712304},{"date":"2023-02-24","current":64.0481,"twenty":16.573519,"median":67.783646,"eighty":434.881702,"marketCap":9895431481},{"date":"2023-03-03","current":63.254141,"twenty":16.938226,"median":67.783646,"eighty":434.881702,"marketCap":9772764834},{"date":"2023-03-10","current":59.897008,"twenty":17.137429,"median":67.783646,"eighty":434.881702,"marketCap":9254087752},{"date":"2023-03-17","current":58.921752,"twenty":17.302081,"median":67.783646,"eighty":434.881702,"marketCap":9103410611},{"date":"2023-03-24","current":60.672212,"twenty":17.624986,"median":67.783646,"eighty":434.881702,"marketCap":9373856762},{"date":"2023-03-31","current":63.279148,"twenty":17.970498,"median":67.68894,"eighty":434.086512,"marketCap":9776628351},{"date":"2023-04-06","current":63.898061,"twenty":18.054957,"median":67.68894,"eighty":434.086512,"marketCap":9872250383},{"date":"2023-04-14","current":64.873317,"twenty":18.158185,"median":67.783646,"eighty":434.881702,"marketCap":10022927524},{"date":"2023-04-21","current":65.367197,"twenty":18.484076,"median":67.783646,"eighty":434.881702,"marketCap":10099231974},{"date":"2023-04-28","current":63.70426,"twenty":18.731906,"median":67.783646,"eighty":434.881702,"marketCap":9842308130},{"date":"2023-05-05","current":146.11832,"twenty":19.078272,"median":68.588653,"eighty":434.881702,"marketCap":9351572473},{"date":"2023-05-12","current":149.137041,"twenty":19.909208,"median":69.22003,"eighty":434.881702,"marketCap":9544770653},{"date":"2023-05-19","current":144.639451,"twenty":20.507993,"median":87.443915,"eighty":434.881702,"marketCap":9256924881},{"date":"2023-05-26","current":140.538259,"twenty":21.155662,"median":90.238157,"eighty":434.881702,"marketCap":8994448566},{"date":"2023-06-02","current":139.028898,"twenty":21.398536,"median":90.937629,"eighty":434.881702,"marketCap":8897849477},{"date":"2023-06-09","current":143.358782,"twenty":21.506213,"median":91.668604,"eighty":434.881702,"marketCap":9174962017},{"date":"2023-06-16","current":147.658173,"twenty":21.60402,"median":92.617131,"eighty":434.881702,"marketCap":9450123060},{"date":"2023-06-23","current":149.18278,"twenty":21.770569,"median":93.488972,"eighty":435.676893,"marketCap":9547697898},{"date":"2023-06-30","current":144.060101,"twenty":21.895923,"median":94.02934,"eighty":436.472083,"marketCap":9219846442},{"date":"2023-07-07","current":143.922886,"twenty":21.989585,"median":94.91316,"eighty":436.472083,"marketCap":9211064707},{"date":"2023-07-14","current":146.407995,"twenty":22.061764,"median":95.529687,"eighty":436.472083,"marketCap":9370111693},{"date":"2023-07-21","current":149.274256,"twenty":22.130933,"median":95.839905,"eighty":436.472083,"marketCap":9553552388},{"date":"2023-07-28","current":154.366443,"twenty":22.209371,"median":96.635182,"eighty":436.472083,"marketCap":9879452347},{"date":"2023-08-04","current":57.179827,"twenty":22.369622,"median":96.794628,"eighty":436.472083,"marketCap":10086521560},{"date":"2023-08-11","current":57.938239,"twenty":22.419379,"median":96.794628,"eighty":436.472083,"marketCap":10220305417},{"date":"2023-08-18","current":57.738949,"twenty":22.500257,"median":96.794628,"eighty":436.472083,"marketCap":10185150535},{"date":"2023-08-25","current":59.27238,"twenty":22.577261,"median":96.794628,"eighty":436.472083,"marketCap":10455647821},{"date":"2023-09-01","current":60.279905,"twenty":22.655218,"median":96.794628,"eighty":436.472083,"marketCap":10633375280},{"date":"2023-09-08","current":60.052935,"twenty":22.776647,"median":96.794628,"eighty":436.472083,"marketCap":10593337776},{"date":"2023-09-15","current":62.986937,"twenty":22.862726,"median":96.982474,"eighty":437.267273,"marketCap":11110895761},{"date":"2023-09-22","current":62.616035,"twenty":22.973265,"median":96.982474,"eighty":437.267273,"marketCap":11045468619},{"date":"2023-09-29","current":63.750885,"twenty":23.123786,"median":96.982474,"eighty":437.267273,"marketCap":11245656142},{"date":"2023-10-06","current":63.828387,"twenty":23.187287,"median":96.982474,"eighty":437.267273,"marketCap":11259327485},{"date":"2023-10-13","current":61.580831,"twenty":23.281362,"median":96.982474,"eighty":437.267273,"marketCap":10862858538},{"date":"2023-10-20","current":61.519936,"twenty":23.429531,"median":96.982474,"eighty":437.267273,"marketCap":10852116768},{"date":"2023-10-27","current":59.742927,"twenty":23.646846,"median":97.20033,"eighty":438.237231,"marketCap":10538652404},{"date":"2023-11-03","current":58.32872,"twenty":23.985048,"median":97.20033,"eighty":438.237231,"marketCap":11140785548},{"date":"2023-11-10","current":57.690854,"twenty":23.985048,"median":95.96752,"eighty":392.709437,"marketCap":11018953164},{"date":"2023-11-17","current":55.952155,"twenty":23.985048,"median":95.589827,"eighty":383.351833,"marketCap":10686861664},{"date":"2023-11-24","current":57.701142,"twenty":23.985048,"median":95.489796,"eighty":377.211039,"marketCap":11020918202},{"date":"2023-12-01","current":59.974826,"twenty":23.985048,"median":94.859599,"eighty":367.477481,"marketCap":11455191702},{"date":"2023-12-08","current":61.728957,"twenty":24.007626,"median":93.696554,"eighty":365.084276,"marketCap":11790230760},{"date":"2023-12-15","current":62.423408,"twenty":24.007626,"median":93.180509,"eighty":363.965151,"marketCap":11922870856},{"date":"2023-12-22","current":62.32567,"twenty":24.007626,"median":91.967766,"eighty":361.900364,"marketCap":11904202990},{"date":"2023-12-29","current":67.979014,"twenty":23.985048,"median":91.60565,"eighty":350.289361,"marketCap":12983991624},{"date":"2024-01-05","current":68.714617,"twenty":23.96247,"median":91.018028,"eighty":348.300433,"marketCap":13124491874},{"date":"2024-01-12","current":67.171393,"twenty":23.96247,"median":90.125498,"eighty":344.013234,"marketCap":12829736105},{"date":"2024-01-19","current":70.34529,"twenty":23.939892,"median":87.443915,"eighty":339.611278,"marketCap":13435950470},{"date":"2024-01-26","current":72.536668,"twenty":23.96247,"median":71.993968,"eighty":332.715749,"marketCap":13854503662},{"date":"2024-02-02","current":73.277416,"twenty":23.96247,"median":71.906519,"eighty":313.773789,"marketCap":13995986431},{"date":"2024-02-09","current":52.891564,"twenty":23.96247,"median":70.886562,"eighty":261.06275,"marketCap":13207023489},{"date":"2024-02-16","current":53.400095,"twenty":23.96247,"median":69.696194,"eighty":257.160449,"marketCap":13334003660},{"date":"2024-02-23","current":53.149035,"twenty":23.96247,"median":68.840647,"eighty":255.027964,"marketCap":13271313941},{"date":"2024-03-01","current":51.965465,"twenty":23.985048,"median":68.588653,"eighty":248.779166,"marketCap":12975776696},{"date":"2024-03-08","current":53.930111,"twenty":23.985048,"median":68.148768,"eighty":244.412047,"marketCap":13466348621},{"date":"2024-03-15","current":55.456397,"twenty":23.985048,"median":67.762962,"eighty":240.453561,"marketCap":13847462308},{"date":"2024-03-22","current":57.281564,"twenty":23.985048,"median":67.173314,"eighty":238.312647,"marketCap":14303206612},{"date":"2024-03-28","current":54.926381,"twenty":23.985048,"median":66.336739,"eighty":235.829511,"marketCap":13715117346},{"date":"2024-04-05","current":54.838709,"twenty":23.96247,"median":65.960543,"eighty":230.641182,"marketCap":13693225698},{"date":"2024-04-12","current":54.753332,"twenty":23.96247,"median":65.52974,"eighty":224.225614,"marketCap":13671906957},{"date":"2024-04-19","current":53.387822,"twenty":23.96247,"median":65.224959,"eighty":214.926531,"marketCap":13330939072},{"date":"2024-04-26","current":55.490466,"twenty":23.985048,"median":65.016713,"eighty":211.299293,"marketCap":13855969266},{"date":"2024-05-03","current":38.063574,"twenty":24.176232,"median":64.926662,"eighty":209.711716,"marketCap":14072103451},{"date":"2024-05-10","current":38.017298,"twenty":24.502187,"median":64.926662,"eighty":209.711716,"marketCap":14054995122},{"date":"2024-05-17","current":38.629778,"twenty":24.632825,"median":64.926662,"eighty":209.711716,"marketCap":14281428883},{"date":"2024-05-24","current":38.248679,"twenty":24.716549,"median":64.926662,"eighty":209.711716,"marketCap":14140536765},{"date":"2024-05-31","current":37.200658,"twenty":24.820876,"median":64.926662,"eighty":209.711716,"marketCap":13753083441},{"date":"2024-06-07","current":36.223413,"twenty":24.997349,"median":64.926662,"eighty":209.711716,"marketCap":13391795796},{"date":"2024-06-14","current":37.091773,"twenty":25.132663,"median":64.971688,"eighty":209.794306,"marketCap":13712828551},{"date":"2024-06-21","current":36.495626,"twenty":25.611349,"median":65.016713,"eighty":209.876896,"marketCap":13492433023},{"date":"2024-06-28","current":36.560957,"twenty":26.148895,"median":65.029383,"eighty":211.299293,"marketCap":13516585958},{"date":"2024-07-05","current":37.628033,"twenty":26.322584,"median":65.029383,"eighty":211.299293,"marketCap":13911083888},{"date":"2024-07-12","current":39.879237,"twenty":26.601174,"median":65.029383,"eighty":211.299293,"marketCap":14743353755},{"date":"2024-07-15","current":40.131034,"twenty":26.615894,"median":65.029383,"eighty":211.299293,"marketCap":14836443190},{"date":"2024-08-02","current":45.591134,"twenty":26.86173,"median":65.123383,"eighty":209.546537,"marketCap":15464512534},{"date":"2024-08-09","current":43.679968,"twenty":26.86173,"median":64.926662,"eighty":203.758652,"marketCap":14816245015},{"date":"2024-08-16","current":43.989565,"twenty":26.86173,"median":64.824841,"eighty":201.969234,"marketCap":14921260314},{"date":"2024-08-23","current":45.418474,"twenty":26.86173,"median":64.529477,"eighty":201.100989,"marketCap":15405946309},{"date":"2024-08-30","current":38.232251,"twenty":26.86173,"median":64.341928,"eighty":199.724972,"marketCap":12968379659},{"date":"2024-09-06","current":36.082934,"twenty":26.86173,"median":64.216895,"eighty":198.7372,"marketCap":12239331141},{"date":"2024-09-13","current":36.103772,"twenty":26.86173,"median":63.998087,"eighty":198.373805,"marketCap":12246399478},{"date":"2024-09-20","current":35.859667,"twenty":26.86173,"median":63.828387,"eighty":196.979242,"marketCap":12163598954},{"date":"2024-09-27","current":34.511134,"twenty":26.86173,"median":63.679253,"eighty":196.20378,"marketCap":11706176546},{"date":"2024-10-04","current":33.305492,"twenty":26.86173,"median":63.327173,"eighty":193.88423,"marketCap":11297222738},{"date":"2024-10-11","current":33.463267,"twenty":26.86173,"median":63.274802,"eighty":189.672156,"marketCap":11350740150},{"date":"2024-10-18","current":35.264288,"twenty":26.86173,"median":63.195636,"eighty":182.652034,"marketCap":11961646456},{"date":"2024-10-25","current":34.389081,"twenty":26.86173,"median":62.986937,"eighty":181.026669,"marketCap":11664776284},{"date":"2024-10-31","current":32.619923,"twenty":26.86173,"median":62.892828,"eighty":179.513625,"marketCap":12588028444},{"date":"2024-11-08","current":32.528095,"twenty":26.852907,"median":62.621935,"eighty":178.558889,"marketCap":12552592025},{"date":"2024-11-15","current":32.238181,"twenty":26.852907,"median":62.553735,"eighty":154.18349,"marketCap":12440714189},{"date":"2024-11-22","current":32.795708,"twenty":26.852907,"median":62.388604,"eighty":149.95728,"marketCap":12655863875},{"date":"2024-11-29","current":33.254848,"twenty":26.852907,"median":62.257511,"eighty":149.213272,"marketCap":12833045969},{"date":"2024-12-06","current":33.168268,"twenty":26.852907,"median":61.886863,"eighty":148.618675,"marketCap":12799634488},{"date":"2024-12-13","current":33.265343,"twenty":26.852907,"median":61.550384,"eighty":147.743551,"marketCap":12837095845},{"date":"2024-12-20","current":35.40887,"twenty":26.852907,"median":61.259752,"eighty":146.444586,"marketCap":13664283108},{"date":"2024-12-27","current":36.476699,"twenty":26.852907,"median":61.063228,"eighty":145.764611,"marketCap":14076358036},{"date":"2025-01-03","current":36.169731,"twenty":26.852907,"median":60.907571,"eighty":144.785813,"marketCap":13957899150},{"date":"2025-01-10","current":36.392742,"twenty":26.844083,"median":60.680648,"eighty":144.044855,"marketCap":14043959024},{"date":"2025-01-17","current":37.234935,"twenty":26.844083,"median":60.329767,"eighty":143.386225,"marketCap":14368961609},{"date":"2025-01-24","current":38.719925,"twenty":26.844083,"median":60.247462,"eighty":142.678807,"marketCap":14942019125},{"date":"2025-01-31","current":40.218033,"twenty":26.844083,"median":59.974826,"eighty":141.016986,"marketCap":15520138987},{"date":"2025-02-07","current":44.648909,"twenty":26.844083,"median":59.754628,"eighty":137.028614,"marketCap":15238672574},{"date":"2025-02-14","current":34.141082,"twenty":26.844083,"median":59.521493,"eighty":131.55311,"marketCap":11652351200},{"date":"2025-02-21","current":33.919064,"twenty":26.844083,"median":59.27238,"eighty":130.444741,"marketCap":11576576519},{"date":"2025-02-28","current":34.328044,"twenty":26.844083,"median":59.040533,"eighty":129.095424,"marketCap":11716161457},{"date":"2025-03-07","current":32.91122,"twenty":26.83526,"median":58.73161,"eighty":127.751461,"marketCap":11232599351},{"date":"2025-03-14","current":31.839108,"twenty":26.83526,"median":58.3673,"eighty":127.30972,"marketCap":10866687407},{"date":"2025-03-21","current":32.154607,"twenty":26.83526,"median":57.889136,"eighty":126.142453,"marketCap":10974367216},{"date":"2025-03-28","current":33.302672,"twenty":26.83526,"median":57.695998,"eighty":125.695358,"marketCap":11366202078},{"date":"2025-04-04","current":30.054201,"twenty":26.83526,"median":57.273606,"eighty":124.678015,"marketCap":10257498857},{"date":"2025-04-11","current":26.501916,"twenty":26.750137,"median":56.720224,"eighty":122.876248,"marketCap":9045103969},{"date":"2025-04-17","current":29.242083,"twenty":26.695569,"median":56.384258,"eighty":119.27935,"marketCap":9980323052},{"date":"2025-04-25","current":30.658387,"twenty":26.680493,"median":56.257145,"eighty":115.693273,"marketCap":10463707627},{"date":"2025-05-02","current":30.898993,"twenty":26.680493,"median":56.044889,"eighty":114.003704,"marketCap":10545826362},{"date":"2025-05-09","current":38.032908,"twenty":26.680493,"median":55.948895,"eighty":113.591967,"marketCap":11630463166},{"date":"2025-05-16","current":38.922888,"twenty":26.680493,"median":55.567979,"eighty":113.591967,"marketCap":11902619171},{"date":"2025-05-23","current":38.550714,"twenty":26.680493,"median":55.400605,"eighty":113.591967,"marketCap":11788808478},{"date":"2025-05-30","current":40.019991,"twenty":26.680493,"median":55.045675,"eighty":113.591967,"marketCap":12238113301},{"date":"2025-06-06","current":40.327439,"twenty":26.680493,"median":54.834724,"eighty":113.591967,"marketCap":12332130830},{"date":"2025-06-13","current":40.456891,"twenty":26.680493,"median":54.478076,"eighty":113.591967,"marketCap":12371717158},{"date":"2025-06-20","current":41.201238,"twenty":26.665418,"median":53.930111,"eighty":113.621107,"marketCap":12599338544},{"date":"2025-06-27","current":41.00706,"twenty":26.665418,"median":53.569084,"eighty":113.621107,"marketCap":12539959052},{"date":"2025-07-03","current":41.783771,"twenty":26.665418,"median":53.336333,"eighty":113.621107,"marketCap":12777477020},{"date":"2025-07-11","current":43.664056,"twenty":26.665418,"median":53.065577,"eighty":113.621107,"marketCap":13352468434},{"date":"2025-07-18","current":43.401917,"twenty":26.665418,"median":52.829249,"eighty":113.621107,"marketCap":13272306120},{"date":"2025-07-25","current":42.602552,"twenty":26.665418,"median":52.511422,"eighty":113.621107,"marketCap":13027860544},{"date":"2025-08-01","current":36.514628,"twenty":26.665418,"median":52.087035,"eighty":113.621107,"marketCap":12718045027},{"date":"2025-08-08","current":35.765712,"twenty":26.665418,"median":51.986859,"eighty":113.621107,"marketCap":12457197656},{"date":"2025-08-15","current":37.391686,"twenty":26.665418,"median":51.677224,"eighty":113.621107,"marketCap":13023524078},{"date":"2025-08-22","current":38.522178,"twenty":26.665418,"median":50.766532,"eighty":113.621107,"marketCap":13417274672},{"date":"2025-08-29","current":39.564396,"twenty":26.665418,"median":49.022556,"eighty":113.621107,"marketCap":13780278999},{"date":"2025-09-05","current":39.980144,"twenty":26.660526,"median":47.055461,"eighty":113.639848,"marketCap":13925084004},{"date":"2025-09-12","current":40.891372,"twenty":26.665418,"median":46.381549,"eighty":113.621107,"marketCap":14242464836},{"date":"2025-09-19","current":41.477975,"twenty":26.665418,"median":46.003612,"eighty":113.621107,"marketCap":14446778746},{"date":"2025-09-26","current":40.119675,"twenty":26.665418,"median":46.003612,"eighty":113.621107,"marketCap":13973682943},{"date":"2025-10-03","current":38.937926,"twenty":26.665418,"median":46.003612,"eighty":113.621107,"marketCap":13562079677},{"date":"2025-10-10","current":39.430559,"twenty":26.665418,"median":45.680316,"eighty":113.621107,"marketCap":13733663689},{"date":"2025-10-17","current":39.160038,"twenty":26.665418,"median":45.489919,"eighty":113.621107,"marketCap":13639441255},{"date":"2025-10-24","current":40.911305,"twenty":26.665418,"median":45.418474,"eighty":113.621107,"marketCap":14249407541},{"date":"2025-10-31","current":32.157417,"twenty":26.665418,"median":45.329167,"eighty":113.621107,"marketCap":13763374551},{"date":"2025-11-07","current":36.06178,"twenty":26.665418,"median":44.861795,"eighty":113.621107,"marketCap":15434442050},{"date":"2025-11-14","current":33.58428,"twenty":26.665418,"median":43.968726,"eighty":113.621107,"marketCap":14374071952},{"date":"2025-11-21","current":32.376397,"twenty":26.665418,"median":43.66806,"eighty":113.621107,"marketCap":13857097908},{"date":"2025-11-28","current":35.446773,"twenty":26.665418,"median":43.352509,"eighty":113.621107,"marketCap":15171219007},{"date":"2025-12-05","current":35.926665,"twenty":26.665418,"median":43.191558,"eighty":113.621107,"marketCap":15376612745},{"date":"2025-12-12","current":36.050133,"twenty":26.665418,"median":42.725532,"eighty":113.621107,"marketCap":15429456765},{"date":"2025-12-19","current":33.042655,"twenty":26.665418,"median":41.783771,"eighty":113.621107,"marketCap":14142256204},{"date":"2025-12-26","current":34.228407,"twenty":26.665418,"median":41.688697,"eighty":113.621107,"marketCap":14649758207},{"date":"2026-01-02","current":33.040325,"twenty":26.665418,"median":41.424542,"eighty":113.621107,"marketCap":14141259147},{"date":"2026-01-09","current":31.582013,"twenty":26.665418,"median":41.053684,"eighty":113.621107,"marketCap":13517101477},{"date":"2026-01-16","current":31.064848,"twenty":26.665418,"median":40.948324,"eighty":113.621107,"marketCap":13295754828},{"date":"2026-01-23","current":32.001336,"twenty":26.665418,"median":40.689904,"eighty":113.246297,"marketCap":13696571734},{"date":"2026-01-30","current":32.138781,"twenty":26.665418,"median":40.57987,"eighty":112.603765,"marketCap":13755398096},{"date":"2026-02-06","current":32.131792,"twenty":26.764151,"median":40.453654,"eighty":110.060408,"marketCap":13752406925},{"date":"2026-02-13","current":25.645156,"twenty":26.870554,"median":40.453654,"eighty":110.060408,"marketCap":12273771423},{"date":"2026-02-20","current":27.282254,"twenty":26.921566,"median":40.453654,"eighty":110.060408,"marketCap":13057286536},{"date":"2026-02-27","current":27.395493,"twenty":26.995123,"median":40.453654,"eighty":110.060408,"marketCap":13111482806},{"date":"2026-03-06","current":27.185791,"twenty":27.241002,"median":40.453654,"eighty":110.060408,"marketCap":13011119343},{"date":"2026-03-13","current":26.795744,"twenty":27.246604,"median":40.453654,"eighty":110.060408,"marketCap":12824443302},{"date":"2026-03-20","current":27.198373,"twenty":27.355854,"median":40.453654,"eighty":110.060408,"marketCap":13017141151},{"date":"2026-03-27","current":27.768763,"twenty":27.410172,"median":40.453654,"eighty":110.060408,"marketCap":13290129770},{"date":"2026-04-02","current":27.798121,"twenty":27.462597,"median":40.453654,"eighty":110.060408,"marketCap":13304180655},{"date":"2026-04-10","current":27.605195,"twenty":27.596807,"median":40.453654,"eighty":110.060408,"marketCap":13211846269},{"date":"2026-04-17","current":26.927857,"twenty":27.596807,"median":40.453654,"eighty":110.060408,"marketCap":12887672283},{"date":"2026-04-24","current":27.360571,"twenty":27.626165,"median":40.453654,"eighty":110.060408,"marketCap":13094769408},{"date":"2026-05-01","current":27.671606,"twenty":27.654794,"median":40.453654,"eighty":110.060408,"marketCap":13243630754},{"date":"2026-05-08","current":22.496668,"twenty":27.694724,"median":40.453654,"eighty":110.060408,"marketCap":15041271956},{"date":"2026-05-15","current":23.919346,"twenty":27.694724,"median":40.453654,"eighty":110.060408,"marketCap":15992474796},{"date":"2026-05-22","current":23.385466,"twenty":27.694724,"median":40.453654,"eighty":110.060408,"marketCap":15635522356},{"date":"2026-05-29","current":23.519312,"twenty":27.715019,"median":40.453654,"eighty":110.223718,"marketCap":15725011841},{"date":"2026-06-05","current":25.167574,"twenty":27.694724,"median":40.453654,"eighty":110.060408,"marketCap":16827039655},{"date":"2026-06-12","current":24.469769,"twenty":27.694724,"median":40.453654,"eighty":110.060408,"marketCap":16360487733},{"date":"2026-06-18","current":23.911827,"twenty":27.694724,"median":40.453654,"eighty":110.060408,"marketCap":15987447297},{"date":"2026-06-26","current":24.690841,"twenty":27.715019,"median":40.453654,"eighty":110.223718,"marketCap":16508296208},{"date":"2026-07-02","current":25.230737,"twenty":27.715019,"median":40.453654,"eighty":110.223718,"marketCap":16869270647},{"date":"2026-07-10","current":27.152706,"twenty":27.715019,"median":40.453654,"eighty":110.223718,"marketCap":18154299430},{"date":"2026-07-17","current":25.799207,"twenty":27.715019,"median":40.453654,"eighty":110.223718,"marketCap":17249349583},{"date":"2026-07-24","current":26.190218,"twenty":27.715019,"median":40.453654,"eighty":110.223718,"marketCap":17510779539},{"date":"2026-07-31","current":26.438018,"twenty":27.727905,"median":40.453654,"eighty":110.387029,"marketCap":18652021846},{"date":"2026-08-07","current":23.027033,"twenty":27.727905,"median":40.453654,"eighty":110.387029,"marketCap":16245572107},{"date":"2026-08-14","current":21.730304,"twenty":27.727905,"median":40.453654,"eighty":110.387029,"marketCap":15330729478},{"date":"2026-08-21","current":22.034315,"twenty":27.727905,"median":40.453654,"eighty":110.387029,"marketCap":15545209250}],"updateTime":1787515778071},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NBIX\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2648252997","title":"Neurocrine Begins Phase 2 Trial of Crinecerfont in Children Under 4 Years With Classic CAH Genetic Condition","url":"https://stock-news.laohu8.com/highlight/detail?id=2648252997","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648252997?lang=en_us&edition=fundamental","pubTime":"2026-07-02 04:56","pubTimestamp":1782939365,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences (NBIX) said late Wednesday it has started a phase 2 clinical trial of crinecerfont in children aged 3 months to under 4 years with classic congenital adrenal hyperplasia, a rare","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1571399168.USD","LU1267930227.SGD","NBIX","LU0154245756.USD","LU2065169927.USD","BK4139","LU2065170008.USD","LU0052756011.USD","LU1267930813.SGD","LU1880398471.USD","BK4588","LU0128525689.USD","LU0006061336.USD","LU0162691827.USD","LU0154245673.USD","SG9999001440.SGD","LU0310799852.SGD","LU0211328371.USD","LU0211327993.USD","LU1880398554.USD","LU0072461881.USD","LU0109394709.USD","LU1983299246.USD","BK4175","LU1267930490.SGD","BK4585","LU0310800965.SGD","LU2065171311.SGD","LU2065171402.SGD","LU0154236417.USD","LU0823416689.USD","LU0792757196.USD","LU0889565916.HKD","LU2324357040.USD","LU0889566641.SGD","LU0320765992.SGD","CAH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648526571","title":"Neurocrine initiates Phase 2 study of crinecerfont","url":"https://stock-news.laohu8.com/highlight/detail?id=2648526571","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648526571?lang=en_us&edition=fundamental","pubTime":"2026-07-02 04:10","pubTimestamp":1782936655,"startTime":"0","endTime":"0","summary":"Neurocrine (NBIX) Biosciences announced the initiation of its Phase 2 clinical study to assess the safety and tolerability of crinecerfont in child...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neurocrine-initiates-phase-2-study-of-crinecerfont-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neurocrine-initiates-phase-2-study-of-crinecerfont-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LU0154245673.USD","LU0109394709.USD","LU2065169927.USD","NBIX","LU2324357040.USD","LU0823416689.USD","LU2065171402.SGD","LU0154245756.USD","LU2065170008.USD","LU2065171311.SGD","LU0320765992.SGD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648525235","title":"Neurocrine Biosciences Announces Press Release Available on Pediatric Crinecerfont Phase 2 CAH Study Initiation","url":"https://stock-news.laohu8.com/highlight/detail?id=2648525235","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648525235?lang=en_us&edition=fundamental","pubTime":"2026-07-02 04:05","pubTimestamp":1782936353,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences announces press release available on pediatric crinecerfont Phase 2 CAH study initiationNeurocrine Biosciences initiated a Phase 2 trial of crinecerfont (CRENESSITY) in children","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nNDL8z0XWc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0154245756.USD","LU0889565916.HKD","LU0109394709.USD","BK4139","LU2065171402.SGD","LU0320765992.SGD","LU2065171311.SGD","LU0823416689.USD","LU2065170008.USD","NBIX","LU2324357040.USD","LU0154245673.USD","LU2065169927.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648525402","title":"Neurocrine Biosciences Initiates Phase 2 Study of Crinecerfont in Pediatric Patients Under 4 Years Old with Classic Congenital Adrenal Hyperplasia","url":"https://stock-news.laohu8.com/highlight/detail?id=2648525402","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648525402?lang=en_us&edition=fundamental","pubTime":"2026-07-02 04:05","pubTimestamp":1782936301,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nTUA3Y3SVN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0154245756.USD","LU0823416689.USD","LU2065170008.USD","BK4139","NBIX","LU2065171402.SGD","LU0889565916.HKD","LU0109394709.USD","LU0320765992.SGD","LU0154245673.USD","LU2065169927.USD","LU2065171311.SGD","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648756297","title":"Neurocrine Biosciences Chief Legal Officer Darin Lippoldt Sells USD 1.91 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2648756297","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648756297?lang=en_us&edition=fundamental","pubTime":"2026-07-01 04:52","pubTimestamp":1782852766,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences Chief Legal Officer Darin Lippoldt sells USD 1.91 million in common sharesNeurocrine Biosciences Chief Legal Officer Darin Lippoldt reported option exercises totaling 10,000 sha","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nNDL8CsR7K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Neurocrine Biosciences Chief Legal Officer Darin Lippoldt Sells USD 1.91 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171402.SGD","LU2065171311.SGD","LU0320765992.SGD","LU2065169927.USD","LU2065170008.USD","LU0154245673.USD","LU0823416689.USD","LU0889565916.HKD","BK4139","LU0154245756.USD","NBIX","LU0109394709.USD","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648356962","title":"Neurocrine Biosciences' Ingrezza Momentum Seen Supporting 2026 Guidance Upgrade, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2648356962","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648356962?lang=en_us&edition=fundamental","pubTime":"2026-07-01 03:18","pubTimestamp":1782847121,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences'  Ingrezza sales momentum could support a 2026 guidance increase, while Vykat growth is expected to slow and major pipeline data are not expected before the second half of 2027, UBS Securities said.The investment firm raised its 2026 Ingrezza sales estimate to $2.80 billion from $2.75 billion, slightly above the $2.78 billion consensus forecast. UBS said changes in insurance coverage for Teva's  Austedo could favor Ingrezza, while Neurocrine's roughly 30% expansion of its sales force should provide additional support.UBS expects Vykat sales growth to slow after strong early demand, forecasting 2026 sales of $235 million, below the $294 million consensus estimate. The brokerage projects peak sales of $616 million, well below the $1.36 billion consensus forecast, reflecting slower patient additions and a higher expected treatment discontinuation rate.The firm said major data from three phase 3 trials of osavampator in major depressive disorder and the first phase 3","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NBIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647559024","title":"Neurocrine (NBIX) Receives a Buy from Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2647559024","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647559024?lang=en_us&edition=fundamental","pubTime":"2026-06-30 21:15","pubTimestamp":1782825349,"startTime":"0","endTime":"0","summary":"In a report released today, from Jefferies maintained a Buy rating on Neurocrine, with a price target of $200.00. In a report released today, UBS a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/neurocrine-nbix-receives-a-buy-from-jefferies-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/neurocrine-nbix-receives-a-buy-from-jefferies-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065171402.SGD","LU2065171311.SGD","LU0320765992.SGD","LU2065169927.USD","LU2065170008.USD","LU0154245673.USD","LU0823416689.USD","LU0889565916.HKD","BK4139","LU0154245756.USD","NBIX","LU0109394709.USD","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647553440","title":"Neurocrine price target raised to $208 from $182 at UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2647553440","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647553440?lang=en_us&edition=fundamental","pubTime":"2026-06-30 18:00","pubTimestamp":1782813618,"startTime":"0","endTime":"0","summary":"UBS raised the firm’s price target on Neurocrine (NBIX) to $208 from $182 and keeps a Buy rating on the shares. Neurocrine is a value-oriented biot...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neurocrine-price-target-raised-to-208-from-182-at-ubs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neurocrine-price-target-raised-to-208-from-182-at-ubs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0823416689.USD","LU0154245756.USD","BK4139","LU2065169927.USD","LU2065170008.USD","LU2065171402.SGD","LU0320765992.SGD","LU2324357040.USD","NBIX","LU0154245673.USD","LU0889565916.HKD","LU2065171311.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647080363","title":"Neurocrine Biosciences, Inc : Jefferies Raises Target Price to $200 from $181","url":"https://stock-news.laohu8.com/highlight/detail?id=2647080363","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647080363?lang=en_us&edition=fundamental","pubTime":"2026-06-29 23:14","pubTimestamp":1782746063,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nFWN4310V8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2065170008.USD","LU2324357040.USD","LU0823416689.USD","LU0320765992.SGD","LU0109394709.USD","LU2065169927.USD","NBIX","LU0154245756.USD","BK4139","LU0889565916.HKD","LU2065171311.SGD","LU0154245673.USD","LU2065171402.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645075016","title":"What Neurocrine Biosciences (NBIX)'s New CRENESSITY CAH Data Means For Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2645075016","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645075016?lang=en_us&edition=fundamental","pubTime":"2026-06-22 21:28","pubTimestamp":1782134933,"startTime":"0","endTime":"0","summary":"Earlier in June 2026, Neurocrine Biosciences reported new data at ENDO 2026 showing CRENESSITY (crinecerfont) delivered strong hormonal control and glucocorticoid-sparing benefits in classic congenital adrenal hyperplasia, including the rarer 11ß-hydroxylase deficiency subtype.\nThe combination of long-term Phase 3 outcomes and first-of-its-kind real-world evidence in this understudied CAH subgroup adds depth to CRENESSITY’s profile in rare endocrine care.\nNext, we’ll consider how this new...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nbix/neurocrine-biosciences/news/what-neurocrine-biosciences-nbixs-new-crenessity-cah-data-me","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nbix/neurocrine-biosciences/news/what-neurocrine-biosciences-nbixs-new-crenessity-cah-data-me","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1880398554.USD","LU0310799852.SGD","LU1571399168.USD","LU0211328371.USD","LU1267930490.SGD","BK4139","LU0162691827.USD","LU0072461881.USD","LU0823416689.USD","LU1267930227.SGD","NBIX","LU0006061336.USD","LU0109394709.USD","LU0889565916.HKD","LU0154236417.USD","LU0792757196.USD","BK4175","LU1880398471.USD","BK4588","LU0310800965.SGD","SG9999001440.SGD","LU2065171311.SGD","LU0889566641.SGD","LU0154245673.USD","LU0128525689.USD","LU2065169927.USD","LU0052756011.USD","LU0154245756.USD","LU2324357040.USD","LU2065170008.USD","BK4585","LU1983299246.USD","LU1267930813.SGD","LU0320765992.SGD","LU0211327993.USD","CAH","LU2065171402.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645029739","title":"Deutsche Bank Raises Neurocrine Biosciences Price Target to $170 From $155, Maintains Hold Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2645029739","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645029739?lang=en_us&edition=fundamental","pubTime":"2026-06-22 19:09","pubTimestamp":1782126583,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences (NBIX) has an average rating of Buy and mean price target of $193.71, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from m","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DB","NBIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645029391","title":"Neurocrine Biosciences, Inc.  : Deutsche Bank Raises Target Price to $170 From $155","url":"https://stock-news.laohu8.com/highlight/detail?id=2645029391","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645029391?lang=en_us&edition=fundamental","pubTime":"2026-06-22 18:58","pubTimestamp":1782125908,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nAQN2M4LO8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0154245756.USD","LU2065171402.SGD","LU0320765992.SGD","BK4139","LU0154245673.USD","LU0823416689.USD","LU2065171311.SGD","NBIX","LU2324357040.USD","LU0109394709.USD","LU2065170008.USD","LU0889565916.HKD","LU2065169927.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645042865","title":"U.S. RESEARCH ROUNDUP-Baldwin Insurance Group, Diamondback Energy, Visteon","url":"https://stock-news.laohu8.com/highlight/detail?id=2645042865","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645042865?lang=en_us&edition=fundamental","pubTime":"2026-06-22 15:47","pubTimestamp":1782114448,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Baldwin Insurance Group, Diamondback Energy, VisteonJune 22 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nL4N42U0H9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AALG","INTC","ABVX","FPS","KMX","INCY","KLAC","LRCX","MUU","ALT","KR","HCA","FANG","ENPH","MRK","LQDA","AGMB","BWIN","MRNX","AMAT","CNXU","MULL","VC","MTDR","BWXT","MRNY","LGN","LINT","ARMK","DFTX","LRCU","DAR","AMRZ","BILL","FMC","GLW","KLAG","APGE","BYD","DCH","FTH","INTW","MU","CHRD","MRNA","ALGM","DAL","NBIX","AAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644288017","title":"Neurocrine’s Valbenazine Huntington Study Completion Signals Next Phase for NBIX Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2644288017","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644288017?lang=en_us&edition=fundamental","pubTime":"2026-06-18 00:30","pubTimestamp":1781713851,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences ($NBIX) announced an update on their ongoing clinical study. The Phase 3 open-label rollover study titled “Open-Label Rollov...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neurocrines-valbenazine-huntington-study-completion-signals-next-phase-for-nbix-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neurocrines-valbenazine-huntington-study-completion-signals-next-phase-for-nbix-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065171311.SGD","LU0109394709.USD","LU0889565916.HKD","NBIX","BK4139","LU0823416689.USD","LU0154245673.USD","LU2065169927.USD","BK4211","LU0154245756.USD","LU2065171402.SGD","LU2065170008.USD","LU2324357040.USD","LU0320765992.SGD","ISBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643851457","title":"Neurocrine presents first retrospective case series of Crenessity","url":"https://stock-news.laohu8.com/highlight/detail?id=2643851457","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643851457?lang=en_us&edition=fundamental","pubTime":"2026-06-16 04:10","pubTimestamp":1781554241,"startTime":"0","endTime":"0","summary":"Neurocrine (NBIX) Biosciences announced clinical findings from the first retrospective case series in pediatric and adult patients with classic con...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neurocrine-presents-first-retrospective-case-series-of-crenessity-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neurocrine-presents-first-retrospective-case-series-of-crenessity-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LU0154245673.USD","LU0109394709.USD","LU2065169927.USD","NBIX","LU2324357040.USD","LU0823416689.USD","LU2065171402.SGD","LU0154245756.USD","LU2065170008.USD","LU2065171311.SGD","LU0320765992.SGD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643720566","title":"Neurocrine presents two-year Crenessity data","url":"https://stock-news.laohu8.com/highlight/detail?id=2643720566","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643720566?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:37","pubTimestamp":1781527061,"startTime":"0","endTime":"0","summary":"Neurocrine (NBIX) Biosciences announced new Phase 3 CAHtalyst Adult study data demonstrating improved cardiometabolic outcomes alongside sustained ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neurocrine-presents-two-year-crenessity-data-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neurocrine-presents-two-year-crenessity-data-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0109394709.USD","LU2065170008.USD","LU2065171311.SGD","LU0154245673.USD","LU0823416689.USD","NBIX","LU2065169927.USD","LU2065171402.SGD","LU0889565916.HKD","LU0154245756.USD","LU2324357040.USD","LU0320765992.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643620581","title":"Neurocrine reports 2-year Phase 3 CAHtalyst Adult data showing cardiometabolic gains with CRENESSITY in classic CAH","url":"https://stock-news.laohu8.com/highlight/detail?id=2643620581","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643620581?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:30","pubTimestamp":1781526654,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences presented new 2-year Phase 3 CAHtalyst Adult data for CRENESSITY  at ENDO 2026.Trial follow-up showed sustained glucocorticoid dose reductions alongside improved cardiometabolic health, including weight-related outcomes and insulin resistance.Bone health measures trended favorably over long-term treatment, supporting a potential reduction in steroid-related skeletal risk.Patient survey results in the open-label extension indicated higher treatment satisfaction, improved quality of life, stronger confidence in managing classic CAH.Safety profile remained consistent through 2 years, with no new long-term safety signals reported.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nNDL1c0j1q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","BK4139","LU2065169927.USD","LU0320765992.SGD","LU0154245756.USD","LU2065171311.SGD","LU0154245673.USD","LU0823416689.USD","LU2065171402.SGD","LU0109394709.USD","LU2324357040.USD","NBIX","LU2065170008.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642047596","title":"Vir Biotechnology names Timothy Coughlin to board, taps him as audit committee chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2642047596","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642047596?lang=en_us&edition=fundamental","pubTime":"2026-06-11 04:05","pubTimestamp":1781121922,"startTime":"0","endTime":"0","summary":"Vir Biotechnology appointed Timothy Coughlin to its board, effective June 9, 2026.He previously served as CFO of Neurocrine Biosciences, helping shift it from clinical-stage to a commercial pharmaceutical company.Earlier roles include vice president of financial services at Catholic Health Initiatives, with prior experience at Ernst & Young.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nNDL5yxn0B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VIR","LU2065171402.SGD","LU2065171311.SGD","LU0320765992.SGD","LU2065169927.USD","LU2065170008.USD","LU0154245673.USD","BK4535","BK4568","LU0823416689.USD","LU0889565916.HKD","BK4139","LU0154245756.USD","NBIX","LU0109394709.USD","BK4585","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642041831","title":"Neurocrine Biosciences director Stephen A. Sherwin disposes of USD 4.12 million in common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2642041831","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642041831?lang=en_us&edition=fundamental","pubTime":"2026-06-10 05:41","pubTimestamp":1781041282,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences director Stephen A. Sherwin cut his direct stake to 15,860 shares via option exercises, followed by stock sales on June 5.Sold 25,000 shares at weighted average prices ranging from USD 163.81 to USD 167.31.Exercised 25,000 non-qualified stock options at USD 53.64 and USD 79.79 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurocrine Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 09, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nNDL5hWGMS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Neurocrine Biosciences director Stephen A. Sherwin disposes of USD 4.12 million in common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU2065169927.USD","LU0154245673.USD","LU0109394709.USD","LU2065170008.USD","LU0823416689.USD","LU0154245756.USD","NBIX","LU2065171402.SGD","LU0320765992.SGD","LU2065171311.SGD","BK4139","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642432461","title":"Neurocrine director Leslie V Norwalk disposes of USD 210,071.63 in common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2642432461","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642432461?lang=en_us&edition=fundamental","pubTime":"2026-06-09 06:08","pubTimestamp":1780956508,"startTime":"0","endTime":"0","summary":"Neurocrine director Leslie V. Norwalk sold 1,250 common shares on June 4, 2026 at an average price of $168.06.Norwalk’s direct holding fell to 2,838 shares following the sale.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurocrine Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 08, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nNDL3ljQZB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Neurocrine director Leslie V Norwalk disposes of USD 210,071.63 in common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU0109394709.USD","LU0823416689.USD","NBIX","LU2065170008.USD","LU0154245756.USD","LU2065171402.SGD","LU2324357040.USD","LU0320765992.SGD","LU2065171311.SGD","LU0154245673.USD","LU2065169927.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":199,"code":"91000000","status":"200"}]}}